Literature DB >> 23138105

Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood.

Tuomas Nikula1, Juha Mykkänen, Olli Simell, Riitta Lahesmaa.   

Abstract

Peripheral whole blood is relatively easily obtained for monitoring gene expression for biomarker discovery using transcriptomic platforms such as genome-wide microarrays. However, whole blood provides challenges caused by sensitivity for ex vivo incubation and overrepresentation of globin mRNAs. We compared the performance of 2 commercial whole blood preservation methods, TEMPUS (Applied Biosystems, Foster City, CA) and PAXgene (PreAnalytiX, Qiagen BD, Valencia, CA), using 2 RNA amplification protocols and high-density microarrays. Performance of commercial globin mRNA reduction protocol also was studied. Human peripheral blood samples collected with TEMPUS and PAXgene Blood RNA tubes were amplified with the RiboAmp OA 1 Round RNA Amplification Kit (Arcturus; Applied Biosystems) and the Affymetrix (Santa Clara, CA) small sample protocol. Affymetrix globin reduction protocol was applied for total RNA samples. Samples amplified with RiboAmp were hybridized on Illumina Sentrix HumanRef-8 Expression BeadChips (Illumina Inc, San Diego, CA) and subjected to statistical analyses. RiboAmp mRNA amplification did not notably amplify globin mRNA that is overrepresented in RNA isolated by both TEMPUS and PAXgene preservation. Enzymatic depletion of globin transcript reduced the quality of total RNA and is thus not recommendable. Microarray analysis showed acceptable correlation within and between the RNA preservation methods, but altogether 443 transcripts were differentially expressed between RNA samples preserved in TEMPUS and PAXgene tubes. We demonstrated that the 2 tested blood RNA-preservation methods combined with RiboAmp mRNA amplification may be used for microarray experiments without the need for a prior globin RNA reduction. However, because genes involved in immune cell functions and gene regulatory pathways were differentially expressed as a result of the technical bias between the preservation methods, they should not be used in the same analytic setting.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138105     DOI: 10.1016/j.trsl.2012.10.003

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  18 in total

Review 1.  Biomarkers in Multiple Sclerosis.

Authors:  Anu Paul; Manuel Comabella; Roopali Gandhi
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

2.  Biomonitoring of Lead Exposure in Children from Two Fishing Communities at Northern Colombia.

Authors:  Liliana Carranza-Lopez; Neda Alvarez-Ortega; Karina Caballero-Gallardo; Audreis Gonzalez-Montes; Jesus Olivero-Verbel
Journal:  Biol Trace Elem Res       Date:  2020-06-01       Impact factor: 3.738

3.  Whole Blood Transcriptome Analysis of Mycoplasma mycoides Subsp. mycoides-Infected Cattle Confirms Immunosuppression but Does Not Reflect Local Inflammation.

Authors:  Valérie Rodrigues; Philippe Holzmuller; Carinne Puech; Hezron Wesonga; François Thiaucourt; Lucía Manso-Silván
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

4.  Biomarkers for monitoring pre-analytical quality variation of mRNA in blood samples.

Authors:  Hui Zhang; Vlasta Korenková; Robert Sjöback; David Švec; Jens Björkman; Mogens Kruhøffer; Paolo Verderio; Sara Pizzamiglio; Chiara Maura Ciniselli; Ralf Wyrich; Uwe Oelmueller; Mikael Kubista; Torbjørn Lindahl; Anders Lönneborg; Edith Rian
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

5.  Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and MiRNA profiles.

Authors:  Madlen Häntzsch; Alexander Tolios; Frank Beutner; Dorothea Nagel; Joachim Thiery; Daniel Teupser; Lesca M Holdt
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

Review 6.  Advances in systems biology approaches for autoimmune diseases.

Authors:  Ho-Youn Kim; Hae-Rim Kim; Sang-Heon Lee
Journal:  Immune Netw       Date:  2014-04-21       Impact factor: 6.303

7.  Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.

Authors:  Manish Kohli; Charles Yf Young; Donald J Tindall; Debashis Nandy; Kyle M McKenzie; Graham H Bevan; Krishna Vanaja Donkena
Journal:  Onco Targets Ther       Date:  2015-07-30       Impact factor: 4.147

8.  Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis.

Authors:  Nadhim Bayatti; Johnathan Cooper-Knock; Joanna J Bury; Matthew Wyles; Paul R Heath; Janine Kirby; Pamela J Shaw
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Long-term storage of blood RNA collected in RNA stabilizing Tempus tubes in a large biobank--evaluation of RNA quality and stability.

Authors:  Nur Duale; W Ian Lipkin; Thomas Briese; Jeanette Aarem; Kjersti S Rønningen; Kaja K Aas; Per Magnus; Kari Harbak; Ezra Susser; Gunnar Brunborg
Journal:  BMC Res Notes       Date:  2014-09-12

10.  Evaluation of Existing Methods for Human Blood mRNA Isolation and Analysis for Large Studies.

Authors:  Anke Meyer; Federico Paroni; Kathrin Günther; Gitanjali Dharmadhikari; Wolfgang Ahrens; Sørge Kelm; Kathrin Maedler
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.